Skip to content

To investigate the anesthetic effect of intravenous general anesthesia with different administration sequence on preoperative painless gastroscopy in obese patients undergoing bariatric surgery

To investigate the anesthetic effect of intravenous general anesthesia with different administration sequence on preoperative painless gastroscopy in obese patients undergoing bariatric surgery

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084998
Enrollment
Unknown
Registered
2024-05-29
Start date
2024-06-03
Completion date
Unknown
Last updated
2024-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

The sequential propofol and remifentanil group (PR group):During intravenous general anesthesia, propofol was administered first followed by remifentanil.
The sequential remifentanil and propofol group (PR group):During intravenous general anesthesia, remifentanil was administered first followed by propofol.

Sponsors

The First Affiliated Hospital of Jinan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1: Patients requiring preoperative painless gastroscopy for bariatric surgery, no gender limit, no age limit. 2: Body mass index (BMI) > 30 kg/m2. 3: ASA grade: I-III. 4: Patients and their families agreed and signed the informed consent for anesthesia.

Exclusion criteria

Exclusion criteria: 1: Patients with central nervous system disorders, psychiatric disorders, or verbal communication disorders. 2: Patients with a history of abnormal surgical anesthesia recovery. 3: Patients allergic to propofol, remifentanil and other anesthetic drugs. 4: Alcohol dependence. 5: Patients who were lactating or had long-term use of opioids or non-steroidal drugs before surgery. 6: Long-term use of ß-blockers and heart rate <50 beats/min. 7: Severe heart, brain, liver, kidney, respiratory dysfunction or dysfunction. 8: Subjects were uncooperative, unavailable for follow-up, or judged by the investigator to be likely to have difficulty completing the study. 9: Other conditions that were judged by the investigator to be ineligible.

Design outcomes

Primary

MeasureTime frame
The incidence of hypoxemia;

Secondary

MeasureTime frame
Duration of hypoxemia;Incidence and duration of severe hypoxemia;Maximum and minimum heart rates;The lowest pulse oxygen saturation ;Coughing/body movement;The satisfaction of the three parties (patients, endoscopists and anesthesiologists) on the effect of anesthesia;The Brice questionnaire;The type of anesthesia to be selected for the next gastroscopy;

Countries

China

Contacts

Public ContactMengxia Wang

The First Affiliated Hospital of Jinan University

wmx_strive@163.com+86 156 2646 7868

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026